The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc. Nov 21, 2009
NEW YORK, Nov. 20, 2009 (GLOBE NEWSWIRE) -- The Brualdi Law Firm, P.C. announces that a lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Hemispherx Biopharma, Inc. ("Hemispherx" or the "Company") (AMEX: - ) stock during the period between February 18, 2009 and October 30, 2009, inclusive (the "Class Period") for violations of the federal securities laws. No class has yet been certified in the above action. (Primezone Releases)
Hemispherx Biopharma responding to FDAs Ampligen questions Nov 3, 2009
Hemispherx Biopharma responding to FDAs Ampligen questions - Philadelphia Business Journal ... Hemispherx Biopharma responding to FDAs Ampligen questions. (Philadelphia Business Journal, PA)
Hemispherx Biopharma to upgrade N.J. plant Sep 17, 2009
for free extra services. Subscribe to Philadelphia Business Journal. (Philadelphia Business Journal, PA)
The following is an investment opinion release issued by Pennystockchaser.com Jun 26, 2009
Also News Release (U-GSS) Golden Star Resources Ltd Also News Release (U-MEA) Metalico IncAlso News Release (U-HEB) Hemispherx BioPharma Inc Also News Release (U-EGO) Eldorado Gold Corp Also News Release (U-NXG) Northgate Minerals Corp ... 86 Sector: Basic Materials, Industry: Mining & Metals - Specialty Hemispherx BioPharma Inc. (AMEX:) up 19% trading at $2. (PR Newswire)
Hemispherx Biopharma Reports On Annual Stockholder Meeting Jun 25, 2009
PHILADELPHIA, June 24, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that it held its 2009 Annual Meeting of Stockholders. Final voting results will be" > Account OptionsNew User? Yahoo! Searchweb search { "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-14400", "open" : "1245936606", "close" : "1245960006", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi. (Primezone Releases)
OffTheWallStocks featuring on its newsletter: WIND, OMEX, FR, AGEN, HEB, NVAX Jun 5, 2009
Today's focused alerts include: Wind River Systems (Nasdaq: ), Odyssey Marine Exploration (Nasdaq: ), First Industrial Realty Trust (NYSE: ), Antigenics Inc Del (Nasdaq: ), Hemispherx Biopharma Inc (AMEX: ), Novavax Inc (Nasdaq: ). OffTheWallStocks. (PR Newswire)
The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate May 28, 2009
CLINTON, N.J., May 27 /PRNewswire/ -- The Sage Group, a privately held international health care consulting group, announced today that HemispherX Biopharma (Amex: ) has expanded the mandate for The Sage Group to include, in addition to the strategic partnering efforts related to Ampligen (an experimental immunotherapeutic) for Chronic Fatigue Syndrome*, additional partnering efforts related to Ampligen's use to increase the effectiveness of preventative pandemic flu vaccines and the additional... (PR Newswire)
Hemispherx to sell up to $16M in stock May 20, 2009
Hemispherx Biopharma to sell up to $16M in stock - Philadelphia Business Journal ... Hemispherx Biopharma to sell up to $16M in stock. (Philadelphia Business Journal, PA)
Hemispherx Biopharma Comments On Market Activity May 16, 2009
Press Release Source: Hemispherx Biopharma, Inc. ... PHILADELPHIA, May 15, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) stated that in view of the unusual market activity in the Company's stock, the NYSE Amex has contacted the Company and requested that the Company issue a public statement indicating as to whether there are any corporate developments which may explain the unusual activity ... About Hemispherx Biopharma. (Primezone Releases)
